Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,19 USD | -1,65% | -1,65% | -61,86% |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 17,64 mln. 16,56 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -17 mln. -15,96 mln. | Nettowinst (verlies) 2023 | -10 mln. -9,39 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 13,25 mln. 12,44 mln. | Nettoliquiditeiten 2023 | 3,84 mln. 3,61 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,65
x | K/w-verhouding 2023 |
-1,53
x | Werknemers | 11 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 28,78% |
Recentste transcriptie over Akari Therapeutics, Plc
1 dag | -1,65% | ||
1 week | -1,65% | ||
Lopende maand | -36,19% | ||
1 maand | -38,66% | ||
3 maanden | -54,23% | ||
6 maanden | -66,48% | ||
Lopend jaar | -61,86% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jacques Suzanne
CEO | Chief Executive Officer | 53 | 28-03-22 |
Founder | 79 | 01-09-15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01-06-16 |
Founder | 79 | 01-09-15 | |
Director/Board Member | 61 | 05-07-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 1,19 | -1,65% | 3 095 |
18-04-24 | 1,21 | +7,92% | 8 776 |
17-04-24 | 1,121 | -2,97% | 7 933 |
16-04-24 | 1,156 | -3,71% | 14 524 |
15-04-24 | 1,2 | -0,83% | 9 109 |
uitgestelde koers Nasdaq, 19 april 2024 om 19:33 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-61,86% | 9,59 mln. | |
-3,35% | 102 mld. | |
+1,64% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,99% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-42,00% | 16,91 mld. | |
-27,98% | 13,79 mld. | |
-0,70% | 13,33 mld. | |
+19,34% | 10,94 mld. |